Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Enric Monreal

Showing results (31-40 of 57) with videos related to

Pageof 6
Sort By:
Journal of Clinical Immunology|November 25, 2020
The Impact of Immunosuppression and Autoimmune Disease on Severe Outcomes in Patients Hospitalized with COVID-19Enric Monreal, Susana Sainz de la Maza, Jose Ignacio Fernández-Velasco, et al.
Frontiers in Neurology|March 1, 2024
Emerging biomarkers for improving pregnancy planning in multiple sclerosisJuan Pablo Cuello, Ariana Meldaña Rivera, Enric Monreal, et al.
Journal of Clinical Medicine|March 28, 2026
Health-Related Quality of Life in Radiologically Isolated Syndrome Resembles Relapsing-Remitting Multiple SclerosisJulián Benito-León, María Díez-Cirarda, Mariano Ruiz-Ortiz, et al.
Journal of Medical Virology|November 9, 2020
Non-severe immunosuppression might be associated with a lower risk of moderate-severe acute respiratory distress syndrome in COVID-19: A pilot studyEnric Monreal, Sainz de la Maza S, Pedro Gullón, et al.
International Journal of Molecular Sciences|September 28, 2024
Association of MicroRNA Expression and Serum Neurofilament Light Chain Levels with Clinical and Radiological Findings in Multiple SclerosisMaría Inmaculada Domínguez-Mozo, Ignacio Casanova, Enric Monreal, et al.
European Journal of Neurology|January 30, 2026
Serum sTREM2 Levels and Disability Progression in Patients With Primary Progressive Multiple SclerosisNicolás Fissolo, Pascal Benkert, Andreu Vilaseca-Jolonch, et al.
Frontiers in Immunology|December 22, 2025
New serum soluble factors predicting inflammatory and non-inflammatory disability worsening in multiple sclerosisAlexander Rodero-Romero, María Domínguez-Mozo, Enric Monreal, et al.
Journal of Personalized Medicine|April 27, 2026
Personalizing Relapsing-Remitting Multiple Sclerosis Monitoring: Patient Acceptance of Serum Neurofilament Light Chain and the Role of Disease KnowledgeÁngel Pérez-Sempere, Elena García-Arcelay, Jacobo Caruncho Pérez, et al.
AJNR. American Journal of Neuroradiology|February 9, 2026
Ventral attention network connectivity differentiates radiologically isolated syndrome from multiple sclerosis: a longitudinal resting-state fMRI studyMaría Díez-Cirarda, Jordi A Matías-Guiu, Mariano Ruiz-Ortiz, et al.
Frontiers in Immunology|August 25, 2025
Identification of cellular factors associated with inflammation and neurodegeneration in multiple sclerosisAlexander Rodero-Romero, José Ignacio Fernández-Velasco, Enric Monreal, et al.
Pageof 6

Showing results (31-40 of 57) with videos related to

Sort By:
Pageof 6
Journal of Clinical Immunology|November 25, 2020
The Impact of Immunosuppression and Autoimmune Disease on Severe Outcomes in Patients Hospitalized with COVID-19Enric Monreal, Susana Sainz de la Maza, Jose Ignacio Fernández-Velasco, et al.
Frontiers in Neurology|March 1, 2024
Emerging biomarkers for improving pregnancy planning in multiple sclerosisJuan Pablo Cuello, Ariana Meldaña Rivera, Enric Monreal, et al.
Journal of Clinical Medicine|March 28, 2026
Health-Related Quality of Life in Radiologically Isolated Syndrome Resembles Relapsing-Remitting Multiple SclerosisJulián Benito-León, María Díez-Cirarda, Mariano Ruiz-Ortiz, et al.
Journal of Medical Virology|November 9, 2020
Non-severe immunosuppression might be associated with a lower risk of moderate-severe acute respiratory distress syndrome in COVID-19: A pilot studyEnric Monreal, Sainz de la Maza S, Pedro Gullón, et al.
International Journal of Molecular Sciences|September 28, 2024
Association of MicroRNA Expression and Serum Neurofilament Light Chain Levels with Clinical and Radiological Findings in Multiple SclerosisMaría Inmaculada Domínguez-Mozo, Ignacio Casanova, Enric Monreal, et al.
European Journal of Neurology|January 30, 2026
Serum sTREM2 Levels and Disability Progression in Patients With Primary Progressive Multiple SclerosisNicolás Fissolo, Pascal Benkert, Andreu Vilaseca-Jolonch, et al.
Frontiers in Immunology|December 22, 2025
New serum soluble factors predicting inflammatory and non-inflammatory disability worsening in multiple sclerosisAlexander Rodero-Romero, María Domínguez-Mozo, Enric Monreal, et al.
Journal of Personalized Medicine|April 27, 2026
Personalizing Relapsing-Remitting Multiple Sclerosis Monitoring: Patient Acceptance of Serum Neurofilament Light Chain and the Role of Disease KnowledgeÁngel Pérez-Sempere, Elena García-Arcelay, Jacobo Caruncho Pérez, et al.
AJNR. American Journal of Neuroradiology|February 9, 2026
Ventral attention network connectivity differentiates radiologically isolated syndrome from multiple sclerosis: a longitudinal resting-state fMRI studyMaría Díez-Cirarda, Jordi A Matías-Guiu, Mariano Ruiz-Ortiz, et al.
Frontiers in Immunology|August 25, 2025
Identification of cellular factors associated with inflammation and neurodegeneration in multiple sclerosisAlexander Rodero-Romero, José Ignacio Fernández-Velasco, Enric Monreal, et al.
Pageof 6